Item 5.07. Submission of Matters to a Vote of Security Holders.

At a special meeting (the "Special Meeting") of stockholders held on October 18, 2022, the stockholders of ChemoCentryx, Inc. (the "Company" or "ChemoCentryx") voted on the proposals set forth below. The proposals are described in detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on September 14, 2022, as supplemented on October 7, 2022 (the "Proxy Statement"). The voting results regarding each proposal, as determined by Carideo Group, the Company's Inspector of Election, are set forth below. As of the close of business on September 13, 2022, the record date of the Special Meeting, there were 71,919,705 shares of common stock of the Company, par value $0.001 per share ("Company Common Stock"), outstanding, each of which was entitled to one vote on each proposal at the Special Meeting. At the Special Meeting, a total of 57,464,094 shares of Company Common Stock, representing approximately 79.90% of the outstanding shares of Company Common Stock entitled to vote, were present in person or represented by proxy, constituting a quorum to conduct business.

Proposal No. 1: Adoption of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of August 3, 2022, among ChemoCentryx, Amgen Inc., a Delaware corporation ("Amgen"), and Carnation Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Amgen ("Merger Sub"), pursuant to which Merger Sub will be merged with and into ChemoCentryx, with ChemoCentryx surviving the Merger as a wholly owned subsidiary of Amgen (the "Merger," and such proposal, the "Merger Proposal").



The Merger Proposal was approved by the requisite vote of the Company's
stockholders.

Votes For    Votes Against   Abstentions   Broker Non-Votes
57,323,711      48,126         92,257             -

Proposal No. 2: Approval, on a non-binding, advisory basis, of certain compensation that will or may be paid or become payable to ChemoCentryx's named executive officers that is based on or otherwise relates to the Merger (the "Merger Compensation Proposal").

The Merger Compensation Proposal was approved by the requisite vote of the Company's stockholders.

Votes For Votes Against Abstentions Broker Non-Votes 47,029,015 9,455,991 979,088

            -

Proposal No. 3: Approval of the adjournment of the Special Meeting to a later date or dates, if necessary to solicit additional proxies if there are insufficient votes to approve the proposal to adopt the Merger Agreement at the time of the Special Meeting (the "Adjournment Proposal").

Adjournment of the Special Meeting was deemed not necessary because there was a quorum present and there were sufficient proxies at the time of the Special Meeting to approve the Merger Proposal.

Votes For Votes Against Abstentions Broker Non-Votes 51,086,057 5,434,877 943,160

            -

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses